Subscribe to RSS
DOI: 10.1055/s-0040-1714296
The Effects of Rheumatoid Arthritis on In-Hospital Lengths of Stay, Complications, and Costs following Primary Total Hip Arthroplasty: A Matched-Control Study
Abstract
Studies investigating the relationship of rheumatoid arthritis (RA) in patients undergoing primary total hip arthroplasty (THA) are limited. Therefore, the purpose of this study was to analyze whether RA patients undergoing primary THA have higher rates of: (1) in-hospital lengths of stay (LOS), (2) medical complications, (3) implant-related complications, and (4) costs of care. A query using an administrative claims database was performed identifying patients who underwent primary THA with RA, whereas patients without RA served as controls. Study group patients were matched to controls in a 1:5 ratio by age, sex, and medical comorbidities. The query yielded 518,927 patients with (n = 86,507) and without (n = 432,420) RA undergoing primary THA. A p-value of less than 0.002 was considered statistically significant. Patients with RA were found to have significantly longer in-hospital LOS (4 vs. 3 days, p < 0.0001). Additionally, RA patients had significantly higher incidence and odds (odds ratio [OR]) of medical (6.39 vs. 1.18%; OR: 5.71, p < 0.0001) and implant-related complications (7.45 vs. 3.35%; OR: 2.32, p < 0.0001) compared with patients without RA. Furthermore, RA patients were found to have significantly higher day of surgery ($12,422.19 vs. $12,103.08, p < 0.0001) and total global 90-day episode of care costs ($16,560.40 vs. $15,167.67, p < 0.0001). This study of 518,927 patients demonstrates patients with RA undergoing primary THA have significantly longer in-hospital LOS, in addition to higher rates of complications and costs. The study is informative as orthopaedists can adequately counsel and educate RA patients of the potential complications which may occur following their procedure.
Publication History
Received: 08 January 2020
Accepted: 05 May 2020
Article published online:
22 September 2020
© 2020. Thieme. All rights reserved.
Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.
-
References
- 1 Firestein G, Budd R, Gabriel S, McInnes I. Kelley's Textbook of Rheumatology. 2012
- 2 Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol 2017; 31 (01) 3-18
- 3 Traylor M, Curtis C, Patel H. , et al. Genetic and environmental risk factors for rheumatoid arthritis in a UK African ancestry population: the GENRA case-control study. Rheumatology (Oxford) 2017; 56 (08) 1282-1292
- 4 Abhishek A, Doherty M, Kuo C-F, Mallen CD, Zhang W, Grainge MJ. Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study. Rheumatology (Oxford) 2017; 56 (05) 736-744
- 5 Onuoha KO, Solow M, Newman JM. , et al. Have the annual trends of total hip arthroplasty in rheumatoid arthritis patients decreased?. Ann Transl Med 2017; 5 (Suppl. 03) S35
- 6 Zwartelé RE, Witjes S, Doets HC, Stijnen T, Pöll RG. Cementless total hip arthroplasty in rheumatoid arthritis: a systematic review of the literature. Arch Orthop Trauma Surg 2012; 132 (04) 535-546
- 7 Jämsen E, Virta LJ, Hakala M, Kauppi MJ, Malmivaara A, Lehto MUK. The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy: a nationwide register-based study from 1995 through 2010. Acta Orthop 2013; 84 (04) 331-337
- 8 Crimmins EM. Lifespan and healthspan: past, present, and promise. Gerontologist 2015; 55 (06) 901-911
- 9 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
- 10 Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 2018; 100 (17) 1455-1460
- 11 Vakharia RM, Cohen-Levy WB, Vakharia AM, Donnally III CJ, Law TY, Roche MW. Sleep apnea increases ninety-day complications and cost following primary total joint arthroplasty. J Arthroplasty 2019; 34 (05) 959-964.e1
- 12 Donnally III CJ, Vakharia RM, Rush III AJ. , et al. Fibromyalgia as a predictor of increased postoperative complications, readmission rates, and hospital costs in patients undergoing posterior lumbar spine fusion. Spine 2019; 44 (04) E233-E238
- 13 Vakharia AM, Cohen-Levy WB, Vakharia RM, Sodhi N, Mont MA, Roche MW. Perioperative complications in patients with rheumatoid arthritis following primary total knee arthroplasty: an analysis of 102,898 patients. J Knee Surg 2019; 32 (11) 1075-1080
- 14 Sabeh KG, Rosas S, Buller LT, Roche MW, Hernandez VH. The impact of discharge disposition on episode-of-care reimbursement after primary total hip arthroplasty. J Arthroplasty 2017; 32 (10) 2969-2973
- 15 Hoes JN, Jacobs JWG, Boers M. , et al. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2007; 66 (12) 1560-1567
- 16 Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am 2011; 93 (24) 2249-2254
- 17 Boylan MR, Perfetti DC, Elmallah RK, Krebs VE, Paulino CB, Mont MA. Does chronic corticosteroid use increase risks of readmission, thromboembolism, and revision after THA?. Clin Orthop Relat Res 2016; 474 (03) 744-751
- 18 Ma Y, Tong H, Zhang X. , et al. Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis. Respir Res 2019; 20 (01) 144
- 19 Albrecht K, Luque Ramos A, Hoffmann F, Redeker I, Zink A. High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data. Rheumatology (Oxford) 2018; 57 (02) 329-336
- 20 Jafri K, Taylor L, Nezamzadeh M. , et al. Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting. BMC Musculoskelet Disord 2015; 16: 237
- 21 Panoulas VF, Metsios GS, Pace AV. , et al. Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47 (09) 1286-1298
- 22 Dar L, Tiosano S, Watad A. , et al. Are obesity and rheumatoid arthritis interrelated?. Int J Clin Pract 2018; 72 (01) e13045
- 23 Hedström AK, Stawiarz L, Klareskog L, Alfredsson L. Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case-control study. Eur J Epidemiol 2018; 33 (04) 415-423
- 24 Somayaji R, Barnabe C, Martin L. Risk factors for infection following total joint arthroplasty in rheumatoid arthritis. Open Rheumatol J 2013; 7: 119-124
- 25 Sabeh KG, Rosas S, Buller LT, Freiberg AA, Emory CL, Roche MW. The impact of medical comorbidities on primary total knee arthroplasty reimbursements. J Knee Surg 2019; 32 (06) 475-482
- 26 Kurowicki J, Rosas S, Khlopas A. , et al. Impact of perioperative hba1c on reimbursements in diabetes mellitus patients undergoing total hip arthroplasty: a nationwide analysis. J Arthroplasty 2018; 33 (07) 2038-2042
- 27 Chen S-Y, Feng Z, Yi X. A general introduction to adjustment for multiple comparisons. J Thorac Dis 2017; 9 (06) 1725-1729
- 28 Chung W-S, Peng C-L, Lin C-L. , et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis 2014; 73 (10) 1774-1780
- 29 Burn E, Edwards CJ, Murray DW. , et al. The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study. Clin Epidemiol 2018; 10: 697-704
- 30 Matta F, Singala R, Yaekoub AY, Najjar R, Stein PD. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 2009; 101 (01) 134-138
- 31 Tropea J, Brand CA, Bohensky M, Van Doornum S. Myocardial infarction and mortality following joint surgery in patients with rheumatoid arthritis: a retrospective cohort study. Arthritis Res Ther 2016; 18: 69
- 32 Kim SC, Schneeweiss S, Liu J, Solomon DH. Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013; 65 (10) 1600-1607
- 33 Zhang P, Liu J, Tan B, Zhu F, Fang L. Hypercoagulable state is associated with NF-kappa B activation and increased inflammatory factors in patients with rheumatoid arthritis [in Chinese]. Xibao Yu Fenzi Mianyixue Zazhi 2016; 32 (03) 364-368
- 34 Ravi B, Croxford R, Hollands S. , et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheumatol 2014; 66 (02) 254-263
- 35 Mibe J, Imakiire A, Watanabe T, Fujie T. Results of total hip arthroplasty with bone graft and support ring for protrusio acetabuli in rheumatoid arthritis. J Orthop Sci 2005; 10 (01) 8-14
- 36 Lin F, Wang X, Liang Y. , et al. Red blood cell distribution width in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis: true inflammatory index or effect of anemia?. Ann Clin Lab Sci 2018; 48 (03) 301-307
- 37 Bucciarelli P, Maino A, Felicetta I. , et al. Association between red cell distribution width and risk of venous thromboembolism. Thromb Res 2015; 136 (03) 590-594
- 38 Rezende SM, Lijfering WM, Rosendaal FR, Cannegieter SC. Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk. Haematologica 2014; 99 (01) 194-200
- 39 Garg N, Syngle A, Krishan P. Nitric oxide: link between inflammation and endothelial dysfunction in rheumatoid arthritis. Int J Angiol 2017; 26 (03) 165-169
- 40 Yang X, Chang Y, Wei W. Endothelial dysfunction and inflammation: immunity in rheumatoid arthritis. Mediators Inflamm 2016; 2016: 6813016
- 41 Totoson P, Maguin-Gaté K, Nappey M, Wendling D, Demougeot C. Endothelial dysfunction in rheumatoid arthritis: mechanistic insights and correlation with circulating markers of systemic inflammation. PLoS One 2016; 11 (01) e0146744
- 42 Castellon X, Bogdanova V. Chronic inflammatory diseases and endothelial dysfunction. Aging Dis 2016; 7 (01) 81-89
- 43 Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000; 43 (03) 522-530
- 44 Lodder MC, de Jong Z, Kostense PJ. , et al. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 2004; 63 (12) 1576-1580
- 45 Lindahl H, Malchau H, Odén A, Garellick G. Risk factors for failure after treatment of a periprosthetic fracture of the femur. J Bone Joint Surg Br 2006; 88 (01) 26-30
- 46 Sarvilinna R, Huhtala HSA, Puolakka TJS, Nevalainen JK, Pajamäki KJJ. Periprosthetic fractures in total hip arthroplasty: an epidemiologic study. Int Orthop 2003; 27 (06) 359-361
- 47 Sato R, Gomez Rey G, Nelson S, Pinsky B. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years. Appl Health Econ Health Policy 2013; 11 (03) 251-258
- 48 Cowper PA, Knight JD, Davidson-Ray L, Peterson ED, Wang TY, Mark DB. TRANSLATE-ACS Investigators. Acute and 1-year hospitalization costs for acute myocardial infarction treated with percutaneous coronary intervention: results from the TRANSLATE-ACS registry. J Am Heart Assoc 2019; 8 (08) e011322
- 49 Parisi TJ, Konopka JF, Bedair HS. What is the long-term economic societal effect of periprosthetic infections after THA? A Markov analysis. Clin Orthop Relat Res 2017; 475 (07) 1891-1900
- 50 Goodman SM, Springer B, Guyatt G. , et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Rheumatol 2017; 69 (08) 1538-1551
- 51 Dixon WG, Suissa S, Hudson M. The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther 2011; 13 (04) R139
- 52 Wallis RS. Biologics and infections: lessons from tumor necrosis factor blocking agents. Infect Dis Clin North Am 2011; 25 (04) 895-910
- 53 Burrus MT, Werner BC, Cancienne JM, Gwathmey FW, Brockmeier SF. Shoulder arthroplasty in patients with Parkinson's disease is associated with increased complications. J Shoulder Elbow Surg 2015; 24 (12) 1881-1887
- 54 Lawson EH, Louie R, Zingmond DS. , et al. A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg 2012; 256 (06) 973-981
- 55 Bedard NA, Pugely AJ, McHugh M. , et al. Analysis of outcomes after TKA: do all databases produce similar findings?. Clin Orthop Relat Res 2018; 476 (01) 52-63